10-Q: InTest Corp. Reports Strong Q1 2026 Revenue Growth

InTest Corporation announced a significant increase in revenue for the first quarter of 2026, driven by strong performance across multiple market segments.

Summary

• InTest Corporation reported a substantial revenue increase of 27.2% to $33.886 million for the first quarter ended March 31, 2026, compared to $26.637 million in the same period last year.
• Gross profit rose by 39.4% to $15.408 million, with gross margin improving to 45.5% from 41.5% year-over-year.
• Operating income turned positive at $0.954 million, a significant improvement from an operating loss of $2.881 million in Q1 2025.
• Net earnings for the quarter were $0.789 million, or $0.06 per diluted share, a substantial turnaround from a net loss of $2.329 million, or ($0.19) per diluted share, in the prior year.
• The company's backlog of unfilled orders stood at $51.8 million as of March 31, 2026, up from $38.2 million in the prior year.
• Restructuring costs increased significantly to $0.744 million due to CEO transition expenses, compared to $0.313 million in the prior year.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth, improved profitability, and a growing backlog, despite some increased restructuring costs and sequential order declines.

Positives

• Revenue increased by 27.2% to $33.886 million in Q1 2026.
• Gross profit increased by 39.4% to $15.408 million.
• Gross margin improved to 45.5% from 41.5% year-over-year.
• Operating income turned positive at $0.954 million, a significant improvement from a loss in the prior year.
• Net earnings of $0.789 million ($0.06 per diluted share) compared to a net loss of $2.329 million ($0.19 per diluted share) in Q1 2025.
• Backlog increased to $51.8 million from $38.2 million year-over-year.
• Orders received increased by 25.4% to $31.785 million compared to the prior year period.
• Strong growth in Defense/Aerospace (105.9%) and Life Sciences (111.6%) markets for revenue.

Negatives

• Restructuring costs increased significantly to $0.744 million due to CEO transition expenses.
• Orders decreased sequentially by 15.2% from Q4 2025, primarily in Life Sciences, Semi, Other, and Safety/Security.
• The company experienced a net cash used in operating activities of $3.315 million for the quarter, an increased usage compared to the prior year period.

Risks

• The company's business and results of operations are substantially dependent on the demand for ATE and wafer production equipment by semiconductor manufacturers, which is cyclical and volatile.
• Potential impact of global supply chain constraints, including sole-source supplier issues in Israel and Belarus, and geopolitical instability.
• The company monitors macroeconomic factors, including changes in global trade policy and tariffs, which could negatively impact demand, pricing, and costs.
• The company's debt agreements contain financial covenants, including a fixed charge coverage ratio, which could be impacted by net losses.
• Customer order cancellations or postponements are possible, affecting backlog and future sales.
• The company's reliance on a relatively few number of customers for a significant portion of its sales.
• Risks associated with foreign operations and currency fluctuations.

Future Outlook

The company anticipates that its current cash and cash equivalents, combined with borrowing capacity under its Revolving Facility and anticipated net cash from operations, will be sufficient to support short-term working capital requirements and other corporate needs. Future long-term cash requirements for growth strategies, including acquisitions, are expected to be funded through a combination of cash, the remaining Term Note availability, or equity issuance.

Management Comments

• The company is focused on diversifying its markets, product offerings, and customer base to reduce dependence on any single market, product, or customer, particularly to mitigate the impact of volatility in the Semi market.
• Management is actively monitoring global macroeconomic factors, including trade policy and tariffs, and taking actions to mitigate risks such as qualifying new vendors, increasing inventory, and ordering further in advance.
• The company is committed to executing its VISION 2030 Strategy and growing its presence in markets outside of the semiconductor automated test equipment (ATE) market.

Industry Context

StockSavvy.ai notes that InTest Corporation's Q1 2026 results reflect a broader industry trend of recovery and growth in specialized technology sectors, particularly in Defense/Aerospace and Life Sciences, while the semiconductor market shows signs of stabilization and growth. The company's strategic diversification efforts are crucial in navigating the cyclical nature of the semiconductor industry.

Comparison to Industry Standards

• InTest's gross margin of 45.5% is strong, especially considering the cyclical nature of the semiconductor industry. Competitors in the ATE market, such as Teradyne and Advantest, typically report gross margins in the range of 40-50%, indicating InTest is performing competitively.
• The revenue growth of 27.2% outpaces the general industrial manufacturing sector average, suggesting effective market penetration and product demand.
• The company's strategic shift towards less cyclical markets like Auto/EV, Defense/Aerospace, and Life Sciences aligns with industry trends where companies are seeking to reduce reliance on the volatile semiconductor market.

Management Changes

Legal Proceedings

• The company is not currently involved in any material legal proceedings.

Related Party Transactions

• As part of the Alfamation acquisition, the company entered into a related-party lease agreement for the seller-owned facility where Alfamation has its principal operations.

Stakeholder Impact

• Shareholders: Positive impact from revenue growth, improved profitability, and increased backlog, though offset by restructuring costs.
• Employees: Potential impact from restructuring costs related to CEO transition; continued employment in growing segments.
• Creditors: Compliance with debt covenants noted, with a waiver on the fixed charge coverage ratio through March 31, 2026.
• Suppliers: Continued monitoring of supply chain risks, particularly for sole-source components.

Next Steps

• Continue to monitor and manage global supply chain risks, including sole-source supplier situations.
• Execute on the VISION 2030 Strategy and further diversify markets and product offerings.
• Manage restructuring costs associated with CEO transition.
• Continue to monitor and comply with debt covenants.
• Pursue acquisition opportunities for complementary businesses, technologies, or products.

Key Dates

Recommendation

The company has demonstrated strong operational improvements with significant revenue growth and a return to profitability. However, the increased restructuring costs, sequential order decline, and ongoing supply chain and geopolitical risks warrant a cautious approach. A 'hold' recommendation reflects the positive operational momentum balanced against these uncertainties.

Keywords

InTest Corporation, INTT, SEC Filing, 10-Q, Quarterly Report, Electronic Test, Environmental Technologies, Process Technologies, Semiconductor Test Equipment, ATE, Revenue Growth, Financial Results, Market Diversification